LBRX

Latest SEC Filings & News for LBRX

1 most recent filing and news item mentioning LBRX. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/LBRX/news?limit=20"

Pull LBRX filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

LB Pharma accelerates NOVA-2 trial timeline, expects H1 2027 data

LB Pharmaceuticals moved up its Phase 3 schizophrenia trial topline results to the first half of 2027 due to rapid enrollment, while maintaining strong capitalization through late 2029.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.